Erector Spinae Block vs. Placebo Block Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorWomen's College Hospital

About this trial

Regional anaesthesia combined with general anaesthesia has become common in the perioperative management of breast cancer surgery patients. Regional techniques have been recognised to provide excellent post-operative analgesia. It enhances multi-modal analgesia regimes while being opioid sparing, reducing incidence of post-operative nausea and vomiting and allowing earlier mobilisation/discharge and improving treatment success. Therefore identifying the correct regional anaesthetic technique for this group of patients is important in providing optimum peri-operative care.

Eligibility criteria

Qualifiers

ASA classification: I-III

BMI < 35 kg/m2

Day surgery procedure

Disqualifiers

Prior ipsilateral breast surgery, excluding lumpectomy

Pre-existing neurological deficit or peripheral neuropathy involving the ipsilateral chest

Severe, poorly controlled cardiac conditions, significant arrhythmias, severe valvular heart diseases

Severe, poorly controlled respiratory conditions (severe COPD, severe interstitial lung disease, severe / poorly controlled asthma)

Trial design

Treatments tested in this trial

  • Erector spinae plane block
  • Placebo Block

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators